Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Cardiovascular diseases (CHRIS baseline)
x0cv23
Right or Left Bundle Branch Block (RBBB, LBBB)
Right or Left Bundle Branch Block (RBBB, LBBB)
Categorical
Cardiovascular diseases (CHRIS baseline)
x0cv23a
Right or Left Bundle Branch Block - from interview + 10sec ECG
Right or Left Bundle Branch Block - from interview + 10sec ECG
Categorical
Cardiovascular diseases (CHRIS baseline)
x0cv24
Any arrhythmic problem + SCA + ECG findings
Any arrhythmic problem + SCA + ECG findings
Categorical
Cardiovascular diseases (CHRIS baseline)
x0cvver
Cardiovascular version
Cardiovascular version
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc01
All requested information received
Q1. I received all the information I sought.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc02
Different sources of information helpful
Q2. Having received information by different means (letter, video, brochure, consultation with the nurse) helped me best to understand the study.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc03
Usability of the electronic informed consent
Q3. Filling-in the electronic informed consent on the computer was difficult.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc04
Consent granularity ensures respect of the will
Q4. Being able to choose between several options ensures that my will is respected.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc05
Regular communication valued
Q5. The awareness that I am receiving regular information about the study gives me peace of mind.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc06
Consent flexibility valuable
Q6. Being able to change the consent granted gives me peace of mind.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dc07
Study endorsement
Q7. I would recommend participation into the CHRIS study to a family member or friend.
Categorical
Dynamic consent survey (CHRIS baseline)
x0dclang
Language used for survey
Language used for survey
Categorical
Drug intake (CHRIS baseline)
x0dd01
Drug usage
Binary indicator of drug usage
Categorical
Drugs summary (CHRIS baseline)
x0dd01a
Drug usage
Drug usage
Categorical
Drug intake (CHRIS baseline)
x0dd02
Type of drug
Type of drug
Categorical
Drugs summary (CHRIS baseline)
x0dd02a
Actual ACT drug usage
Actual ACT drug usage
Categorical
Drug intake (CHRIS baseline)
x0dd04
ATC 1st level of classification
ATC 1st level of classification - anatomical main group
Categorical
Drug intake (CHRIS baseline)
x0dd09
Route of administration
Route of administration
Categorical
Drug intake (CHRIS baseline)
x0dd11
Prescribed by doctor
Drug prescribed by the doctor (Decreed)
Categorical
Drug intake (CHRIS baseline)
x0dd12
Taking mode
Taking mode
Categorical
Drug intake (CHRIS baseline)
x0dd13
Taking frequency
Taking frequency (Taking Interval)
Categorical
Drug intake (CHRIS baseline)
x0dd14
Duration of therapy
Length/duration of treatment/therapy (Taking Period)
Categorical
Drug intake (CHRIS baseline)
x0dd15
Taken today
Taken today
Categorical
Drug intake (CHRIS baseline)
x0dd19
Study assistant
Study assistant
Categorical
Drugs summary (CHRIS baseline)
x0dd20
Anti-hypertensive medication
Anti-hypertensive medication
Categorical
Drugs summary (CHRIS baseline)
x0dd21
Diabetes medication
Diabetes medication
Categorical
Drugs summary (CHRIS baseline)
x0dd22
Lipid modifying agents
Lipid modifying agents
Categorical
Drugs summary (CHRIS baseline)
x0dd23
Metabolic syndrome specific medication
Metabolic syndrome specific medication
Categorical
Drugs summary (CHRIS baseline)
x0dd24
Thyroid medication
Thyroid medication
Categorical
Drugs summary (CHRIS baseline)
x0dd25
Asthma-COPD medication
Asthma-COPD medication
Categorical
Drugs summary (CHRIS baseline)
x0dd26
Osteoporosis medication
Osteoporosis medication
Categorical
Drugs summary (CHRIS baseline)
x0dd27
Antiglaucoma medication
Antiglaucoma medication
Categorical
Drugs summary (CHRIS baseline)
x0dd28
Arthritis medication
Arthritis medication
Categorical
Drugs summary (CHRIS baseline)
x0dd29
Antineoplastic and immunomodulating agents
Antineoplastic and immunomodulating agents
Categorical
Drugs summary (CHRIS baseline)
x0dd30
Angina medication
Angina medication
Categorical
Drugs summary (CHRIS baseline)
x0dd31
Beta blockers
Beta blockers
Categorical
Drugs summary (CHRIS baseline)
x0dd32
Class I and III antiarrhythmics
Class I and III antiarrhythmics
Categorical
Drugs summary (CHRIS baseline)
x0dd33
Digoxin
Digoxin
Categorical
Drugs summary (CHRIS baseline)
x0dd34
Calcium antagonist
Calcium antagonist
Categorical
Drugs summary (CHRIS baseline)
x0dd35
Cardiac therapy
Cardiac therapy
Categorical
Drugs summary (CHRIS baseline)
x0dd36
Antithrombotics
Antithrombotics
Categorical
Drugs summary (CHRIS baseline)
x0dd37
Acid related disorders
Acid related disorders
Categorical
Drugs summary (CHRIS baseline)
x0dd38
Psycholeptics
Psycholeptics
Categorical
Drugs summary (CHRIS baseline)
x0dd39
Psychoanaleptics
Psychoanaleptics
Categorical
Drugs summary (CHRIS baseline)
x0dd40
Sex hormones
Sex hormones
Categorical
Drugs summary (CHRIS baseline)
x0dd41
Anti-Parkinson drugs
Anti-Parkinson drugs
Categorical
Drugs summary (CHRIS baseline)
x0dd42
Hypnotics and sedatives
Hypnotics and sedatives
Categorical
Drugs summary (CHRIS baseline)
x0dd43
Antivertigo preparations
Antivertigo preparations
Categorical
Drugs summary (CHRIS baseline)
x0dd44
Warfarin
Warfarin
Categorical
Drugs summary (CHRIS baseline)
x0dd45
Antiepileptics
Antiepileptics
Categorical
Drug intake (CHRIS baseline)
x0dd46
ATC rescued during QC
ATC rescued during data QC
Categorical
Oral health (CHRIS baseline)
x0dd51
Antibiotics (last 3 months)
Have you taken antibiotics during the last 3 months?
Categorical
Diabetes (CHRIS baseline)
x0dm00
Diabetes (diagnosed)
Do you have diabetes mellitus?
Categorical
Diabetes (CHRIS baseline)
x0dm02
Type of diabetes
Do you know which type of diabetes you have?
Categorical
Diabetes (CHRIS baseline)
x0dm03
Diabetes treatment
How are you treated?
Categorical
Diabetes (CHRIS baseline)
x0dmver
Diabetes version
Diabetes version
Categorical
Depression (CHRIS baseline)
x0ds01
CES-D #1 (I was bothered by things that usually don't bother me)
1. I was bothered by things that usually don't bother me
Categorical
Depression (CHRIS baseline)
x0ds02
CES-D #2 (I did not feel like eating; my appetite was poor)
2. I did not feel like eating; my appetite was poor
Categorical
Depression (CHRIS baseline)
x0ds03
CES-D #3 (I felt that I could not shake off the blues ...)
3. I felt that I could not shake off the blues ...
Categorical
Depression (CHRIS baseline)
x0ds04
CES-D #4 (I felt I was just as good as other people)
4. I felt I was just as good as other people
Categorical
Depression (CHRIS baseline)
x0ds05
CES-D #5 (I had trouble keeping my mind on what I was doing)
5. I had trouble keeping my mind on what I was doing
Categorical
Depression (CHRIS baseline)
x0ds06
CES-D #6 (I felt depressed)
6. I felt depressed
Categorical
Depression (CHRIS baseline)
x0ds07
CES-D #7 (I felt that everything I did was an effort)
7. I felt that everything I did was an effort
Categorical
Depression (CHRIS baseline)
x0ds08
CES-D #8 (I felt hopeful about the future)
8. I felt hopeful about the future
Categorical
Depression (CHRIS baseline)
x0ds09
CES-D #9 (I thought my life had been a failure)
9. I thought my life had been a failure
Categorical
Depression (CHRIS baseline)
x0ds10
CES-D #10 (I felt fearful)
10. I felt fearful
Categorical
Depression (CHRIS baseline)
x0ds11
CES-D #11 (My sleep was restless)
11. My sleep was restless
Categorical
Depression (CHRIS baseline)
x0ds12
CES-D #12 (I was happy)
12. I was happy
Categorical
Depression (CHRIS baseline)
x0ds13
CES-D #13 (I talked less than usual)
13. I talked less than usual
Categorical
Depression (CHRIS baseline)
x0ds14
CES-D #14 (I felt lonely)
14. I felt lonely
Categorical
Depression (CHRIS baseline)
x0ds15
CES-D #15 (People were unfriendly)
15. People were unfriendly
Categorical
Depression (CHRIS baseline)
x0ds16
CES-D #16 (I enjoyed life)
16. I enjoyed life
Categorical
Depression (CHRIS baseline)
x0ds17
CES-D #17 (I had crying spells)
17. I had crying spells
Categorical
Depression (CHRIS baseline)
x0ds18
CES-D #18 (I felt sad)
18. I felt sad
Categorical
Depression (CHRIS baseline)
x0ds19
CES-D #19 (I felt that people dislike me)
19. I felt that people dislike me
Categorical
Depression (CHRIS baseline)
x0ds20
CES-D #20 (I could not get 'going')
20. I could not get 'going'
Categorical
Depression (CHRIS baseline)
x0ds22
Positive at CES-D score
Positive at CES-D score
Categorical
Depression (CHRIS baseline)
x0ds31
CES-D mania #1 (I was unusually happy, excited or elated)
21. I was unusually happy, excited or elated.
Categorical
Depression (CHRIS baseline)
x0ds32
CES-D mania #2 (I hardly needed any sleep nor did I have the desire to sleep)
22. I hardly needed any sleep nor did I have the desire to sleep.
Categorical
Depression (CHRIS baseline)
x0ds33
CES-D mania #3 (My thoughts raced through my mind)
23. My thoughts raced through my mind.
Categorical
Depression (CHRIS baseline)
x0ds34
CES-D mania #4 (I was extremely active and occupied myself with several things)
24. I was extremely active and occupied myself with several things.
Categorical
Depression (CHRIS baseline)
x0ds35
CES-D mania #5 (I couldn’t sit still and felt compelled to do something)
25. I couldn’t sit still and felt compelled to do something.
Categorical
Depression (CHRIS baseline)
x0ds36
CES-D mania #6 (I thought I possessed special abilities or powers)
26. I thought I possessed special abilities or powers.
Categorical
Depression (CHRIS baseline)
x0ds37
CES-D mania #7 (I was very irritable)
27. I was very irritable.
Categorical
Depression (CHRIS baseline)
x0ds38
CES-D mania #8 (I was easily distracted and constantly lost my flow of thoughts)
28. I was easily distracted and constantly lost my flow of thoughts.
Categorical
Depression (CHRIS baseline)
x0ds39
CES-D mania #9 (I spoke a lot more or faster)
29. I spoke a lot more or faster.
Categorical
Depression (CHRIS baseline)
x0dsver
CES-D version
CES-D version
Categorical
ECG 10s (CHRIS baseline)
x0ec145
Heart axis type
Heart axis type
Categorical
ECG 10s (CHRIS baseline)
x0ec148
Original Customed Version
Original version of Custo Software at the time of the ECG exam acquisition
Categorical
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec77
Indication of atrial fibrillation
Indication of atrial fibrillation
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78
Early repolarization (ERP)
Early repolarization (ERP)
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78a
Early repolarization: Rhythm
Early repolarization: Rhythm
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78b
Early repolarization: Region
Early repolarization: Region
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78d
Early repolarization: Type
Early repolarization: Type
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78e
Early repolarization: ST-segment
Early repolarization: ST-segment
Categorical
Early repolarization pattern (CHRIS baseline)
x0ec78f
Note ER analysis: LBBB, RBBB, PM, quality
Note ER analysis: LBBB, RBBB, PM, quality
Categorical
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ecbatch
HRV batch
HRV batch
Categorical
Exposure (CHRIS baseline)
x0ex01
Highway (within 1 km of the habitation)
Is the habitation in which you lived for the longest period, in close proximity (less than 1km) from one of the following facilities? Highway within 1 km
Categorical
Exposure (CHRIS baseline)
x0ex02
Farm (within 1 km of the habitation)
Is the habitation in which you lived for the longest period, in close proximity (less than 1km) from one of the following facilities? Farm within 1 km
Categorical
Exposure (CHRIS baseline)
x0ex03
Plant nursery (within 1 km of the habitation)
Is the habitation in which you lived for the longest period, in close proximity (less than 1km) from one of the following facilities? Plant nursery within 1 km
Categorical
Previous
1
23
24
25
26
27
43
Next